and Jeremy DeLuca Plead Guilty to Violating FDCA


A three-year investigation, resulting in six guilty pleas to charges of distributing misbranded drugs, wrapped up today when and its former president, Jeremy DeLuca, admitted to violating the Food, Drug and Cosmetic Act. agreed to pay $7 million in fines and DeLuca agreed to a $600,000 fine. As part of a plea agreement, with federal prosecutors, DeLuca would not sentenced to any time behind bars, but Chief U.S. District Judge B. Lynn Winmill will have the final say on Aug. 1, the day of DeLuca's sentencing.

"The FDA's Office of Criminal Investigations is fully committed to investigating and supporting the prosecution of those who sell synthetic steroids or steroid clones but call them dietary supplements," said Thomas Emerick, special agent in charge from the FDA's Los Angeles office.

The plea agreements state that between March 2006 and September 2009,, LLC, sold five products misbranded as dietary supplements, when they were actually drugs. The five products were I Force Methadrol, Nutra Costal D-Stianozol, I Force Dymethazine, Rage RV5, and Genetic Edge Technologies (GET) SUS500.

According to the plea agreements, the products were drugs because they contained synthetic anabolic steroids or synthetic chemical “clones” of anabolic steroids that were not dietary supplements, and because they were labeled and promoted as products intended to affect the structure and function of the human body, building muscle mass.